Pyszczymuka Greg
- SEC CIK
- 0001952920
No open-market purchases or sales filed in the past year.
Current role at each company
- AYTU Aytu Biopharma, IncChief Commercial Officeras of Jul 30, 2026
- EVOK Evoke Pharma IncDirectoras of Dec 17, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Pyszczymuka Greg as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AYTU Aytu Biopharma, Inc
Chief Commercial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 (view filing) | Jun 16 | 4 days | Pyszczymuka GregChief Commerical Officer | PPurchase | +12.0K | $1.87 | +$22.4K | +120.8%21.9K after | |
| Dec 21, 2022 (view filing)9:15 AM ET | Dec 19 | 2 days | Pyszczymuka GregChief Commercial Officer | PPurchase | +100.0K | $0.2448 | +$24.5K | +121.9%182.1K after |